Howe & Rusling Inc Aurinia Pharmaceuticals Inc. Transaction History

Howe & Rusling Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 15, 2020	SELL	$14.12 - $18.33 $7,949 - $10,319	-563 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$11.34 - $21.46 $442 - $836	-39 Reduced 6.48%	563 $8,000
Q2 2019 Aug 12, 2019	SELL	$6.05 - $6.75 $187 - $209	-31 Reduced 4.9%	602 $4,000
Q1 2019 Apr 29, 2019	SELL	$6.06 - $7.64 $199 - $252	-33 Reduced 4.95%	633 $4,000
Q4 2018 Feb 04, 2019	BUY	$5.08 - $6.83 $1,417 - $1,905	279 Added 72.09%	666 $5,000
Q1 2018 May 14, 2018	SELL	$4.85 - $5.99 $324 - $401	-67 Reduced 14.76%	387 $2,000
Q3 2017 Oct 18, 2017	BUY	$5.71 - $6.9 $2,592 - $3,132	454	454 $3,000

208

58.6M

1.14M

1.51M

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.26B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

Get notified when there are updates to the investment portfolio of Howe & Rusling Inc, based on Form 13F filings with the SEC.

Stay updated on Howe & Rusling Inc with notifications on news.